Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
5,594 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Looking for tech stocks with staying power? This guide breaks down how to pick what best tech stocks to hold for the ...
Structure Therapeutics stock has surged after a major hedge fund increased its stake. This article breaks down what s...
Cava's yearly revenue just crossed the $1 billion mark, signaling a major milestone for the fast-casual chain. This a...
A sharp drop in Oddity Tech shares sparked questions about the health of a high-growth tech play. Even with solid qua...
Signet Jewelers has shown momentum, but timing the entry is tricky. This guide breaks down fundamentals, market dynam...
BlueStem Wealth Partners disclosed a substantial new stake in VictoryShares Short-Term Bond ETF (USTB) during the lat...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Molson Coors shares fell sharply after a disappointing quarter and a formal downgrade from a major bank. This article...
Meme coins can surprise with sudden moves, and Pepe is no exception. This article unpacks the drivers behind a sharp ...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...